ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,598Medicare Part D Prescriptions Filled, Including Refills

Rank: 250 out of 1844

$583K Total Retail Price of All Prescriptions

Rank: 251 out of 1844

472 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 5,619 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 541 210 S3 1 2
LEVOTHYROXINE SODIUM 322 209 2 1
OMEPRAZOLE 281 183 3 5
AMLODIPINE BESYLATE 277 200 4 6
LISINOPRIL 270 212 5 4
SIMVASTATIN 252 144 6 3
FUROSEMIDE 227 200 7 7
POTASSIUM CHLORIDE 153 127 8 16
METFORMIN HCL 148 85 9 8
TRAMADOL HCL 139 43 10 18
NEXIUM 138 51 11 31
PROAIR HFA 133 45 12 45
PANTOPRAZOLE SODIUM 123 74 13 32
PROMETHAZINE HCL 117 40 R 14 88
AZITHROMYCIN 116 64 15 37
ZOLPIDEM TARTRATE 115 57 16 23
SPIRIVA 110 72 17 57
WARFARIN SODIUM 107 81 18 13
ATORVASTATIN CALCIUM 104 73 19 12
NAMENDA 103 103 20 33
METOPROLOL TARTRATE 101 60 21 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 68 22 20
SERTRALINE HCL 100 69 22 21
METOPROLOL SUCCINATE 95 76 24 14
ADVAIR DISKUS 95 63 24 51
ATENOLOL 93 63 26 17
MELOXICAM 92 79 27 28
PRAVASTATIN SODIUM 80 48 28 10
ALLOPURINOL 79 46 29 29
DONEPEZIL HCL 75 67 30 26
CYMBALTA 71 34 31 36
CYCLOBENZAPRINE HCL 71 0 R 31 53
TRIAMTERENE-HCTZ 70 50 33 48
PREDNISONE 69 36 34 40
DICLOFENAC SODIUM 68 36 35 122
CITALOPRAM HBR 68 39 35 19
TRAZODONE HCL 68 41 35 43
CIPROFLOXACIN HCL 66 47 38 62
GABAPENTIN 65 33 39 15
TAMSULOSIN HCL 65 53 39 27
CELEBREX 63 35 41 91
MIRTAZAPINE 62 38 42 49
ROPINIROLE HCL 61 34 43 76
HYDROCHLOROTHIAZIDE 61 21 43 9
TIZANIDINE HCL 61 0 43 141
RISPERIDONE 56 40 46 65
ESCITALOPRAM OXALATE 55 29 47 52
SINGULAIR 50 30 48 102
DIVALPROEX SODIUM 50 23 48 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.